WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mineralys Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Malcom RodmanChief Medical Officer2025-09-152,065$36.48
$75.32kSell
David Malcom RodmanChief Medical Officer2025-09-159,302$35.90
$333.94kSell
Srinivas AkkarajuDirector2025-09-04588,235$25.50
$15.00MBuy
Ra Capital Management LPDirector2025-09-041,176,470$25.50
$30.00MBuy
David Malcom RodmanChief Medical Officer2025-08-1311,365$12.93
$146.98kSell
David Malcom RodmanChief Medical Officer2025-08-126,349$1.08
$6.86kBuy
Adam Scott LevyCFO and Secretary2025-07-3051,500$14.70
$757.15kSell
Adam Scott LevyCFO and Secretary2025-07-308,425$15.10
$127.20kSell
Adam Scott LevyCFO and Secretary2025-07-29807$14.01
$11.30kSell
Adam Scott LevyCFO and Secretary2025-07-2812,946$14.04
$181.80kSell

1 of 5

MLYS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MLYS insiders and whales buy or sell their stock.

MLYS Shareholders

What type of owners hold Mineralys Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Srinivas Akkaraju17.10%11,338,067$424.27MInsider
Samsara Biocapital GP LLC16.22%10,749,832$402.26MInsider
Brian Taylor Slingsby13.43%8,903,838$333.18MInsider
Catalys Pacific LLC13.43%8,903,838$333.18MInstitution
Ra Capital Management LP9.27%6,147,280$230.03MInstitution
Samsara Biocapital LLC8.56%5,674,916$212.36MInstitution
Ra Capital Management LP5.63%3,734,458$139.74MInsider
Hbm Healthcare Investments Cayman Ltd4.85%3,218,106$120.42MInsider
Sr One Capital Management LP4.72%3,127,933$117.05MInstitution
Blackrock Inc4.67%3,097,760$115.92MInstitution

1 of 3

MLYS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MLYS62.74%37.26%Net BuyingNet Buying
FOLD66.49%33.51%Net SellingNet Selling
VCYT66.68%33.32%Net SellingNet Selling
CPRX82.70%15.97%Net BuyingNet Buying
VKTX67.75%8.98%Net SellingNet Selling
View Top Biotech Stocks

Mineralys Therapeutics Stock Ownership FAQ

Who owns Mineralys Therapeutics?

Mineralys Therapeutics (NASDAQ: MLYS) is owned by 99.08% institutional shareholders, 58.84% Mineralys Therapeutics insiders, and 0.00% retail investors. Srinivas Akkaraju is the largest individual Mineralys Therapeutics shareholder, owning 11.34M shares representing 17.10% of the company. Srinivas Akkaraju's Mineralys Therapeutics shares are currently valued at $422.80M.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.